The in-service evaluation of newborn screening for spinal muscular atrophy (SMA) launched across Scotland in March and is the ...

The first baby in Scotland to be identified with Spinal Muscular Atrophy (SMA) through the country's newborn screening programme has ...

Lucknow: Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) has begun providing a ‘Made in India’ oral ...

Spinal muscular atrophy (SMA) and spina bifida are distinct conditions that affect the nerves that allow for voluntary motor control. Share on Pinterest press coverage photography/Getty Images SMA is ...

Oral risdiplam (Evrysdi, Genentech) started in the first 6 weeks of life let most infants with presymptomatic spinal muscular atrophy (SMA) reach motor milestones typical of healthy babies, results of ...

All newborn babies in England will be tested for the genetic disease spinal muscular atrophy (SMA), as part of a major study. All newborn babies in England will be tested for the genetic disease ...

Spinal muscular atrophy (SMA) is a genetic neuromuscular disease affecting specialized nerve cells that control voluntary muscle movement, according to the Muscular Dystrophy Association (MDA). It can ...

An international study has discovered that people living with the neurodegenerative condition spinal muscular atrophy (SMA) are at higher risk of developing fatty liver disease, suggesting that SMA ...

Baby Rishwanth has SMA Type 1, a rare genetic disease that progressively weakens muscles needed for movement, swallowing and ...

Infantile spinal muscular atrophy (SMA) is a neuromuscular disorder that affects the nerve cells in the spinal cord. It causes muscles to weaken and limits muscle movement. SMA is a rare condition.

"Managing pain in patients with SMA begins with the recognition that there are predictable etiologies leading to pain in SMA and investigating them during each medical visit is important to implement ...

Panelists discuss how spinal muscular atrophy is an autosomal recessive genetic disease affecting motor neurons with 3 currently approved disease-modifying therapies that restore SMN protein ...